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Abstract 
The use of high linear energy transfer radiations in the form of carbon ions in heavy ion beam 
lines or alpha particles in new radionuclide treatments has increased substantially over the past 
decade and will continue to do so due to the favorable dose distributions they can offer versus 
conventional therapies. Previously it has been shown that exposure to heavy ions induces pan-
nuclear phosphorylation of several DNA repair proteins such as H2AX and ATM in vitro. Here 
we describe similar effects of alpha particles on ex vivo irradiated primary human peripheral 
blood lymphocytes. Following alpha particle irradiation pan-nuclear phosphorylation of H2AX 
and ATM, but not DNAPK and 53BP1, was observed throughout the nucleus. Inhibition of 
ATM, but not DNA-PK, resulted in the loss of pan-nuclear phosphorylation of H2AX in alpha 
particle irradiated lymphocytes. Pan-nuclear gamma-H2AX signal was rapidly lost over 24 hours 
at a much greater rate than foci loss. Surprisingly, pan-nuclear gamma-H2AX intensity was not 
dependent on the number of alpha particle induced double strand breaks, rather the number of 
alpha particles which had traversed the cell nucleus. This distinct fluence dependent damage 
signature of particle radiation is important in both the fields of radioprotection and clinical 
oncology in determining radionuclide biological dosimetry and may be indicative of patient 
response to new radionuclide cancer therapies. 
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Introduction 
The phosphorylated histone variant gamma-H2AX is a sensitive and well established biomarker 
of exposure to ionising radiation [1, 2]. Detection of X-ray induced DNA double strand breaks 
(DSBs) by gamma-H2AX foci/intensity quantification has proved useful for biological dosimetry  
[3] and for investigating intra-cell and inter-individual responses to low linear energy transfer 
(LET) radiation [4]. For high LET exposures, such as those induced by heavy ions or alpha 
particles, slower repair of DSBs has been observed, likely due to the greater complexity and 
subsequent greater difficulty in resolving the break [5]. This has been demonstrated by the bi-
exponential repair of low LET induced DSBs, containing both a rapid and slow component [3], 
whereas high LET induced DSBs are lost at a slower rate with greater numbers of residual DSBs 
remaining several hours post exposure compared to X-rays. While both low and high LET 
induced DSBs can be identified using a number of molecular techniques, distinguishing between 
low and high LET breaks is somewhat more difficult. In biological dosimetry, the use of the 
dicentric assay has proved useful in identifying high LET radiation exposures from low LET due 
to the formation of complex aberrations generated by high LET radiation [6, 7]. These types of 
aberrations are more frequent as a result of the formation of densely clustered DSBs caused by 
high LET particles leading to misrepair events not observed with sparsely induced DSBs from, 
for example, X-rays [8].  
With respects to DSBs, it has been observed that in vitro heavy ion irradiation can induce not 
only phosphorylation of H2AX at DSBs, but also throughout the nucleus outside of directly 
induced DSBs [9]. This pan-nuclear phosphorylation of H2AX (and ATM) was not observed 
after X-ray exposure, suggesting it is a phenomenon associated with high LET radiation only. In 
clinical oncology, radionuclides are used extensively in the treatment of thyroid cancer (iodine-
131), in prostate brachytherapy (iodine-125, palladium-103) and bone metastasis (strontium-90, 
samarium-153). For these treatments, the radionuclides are exclusively low LET radiation 
emitters of X- and gamma-rays and beta electrons. More recently the clinical benefit of utilising 
high LET radionuclides has been demonstrated in a phase III clinical trial [10]. In men with 
castrate resistant prostate cancer with bone metastases, those treated with the alpha particle 
emitter radium-223 had a median overall survival of 14.9 months vs. 11.3 in the placebo control 
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group (hazard ratio 0.70). Previously treatment with beta electron emitting radionuclides had 
shown no overall survival benefit, only pain relief [11-13].  
If pan-nuclear phosphorylation of H2AX is present in high LET irradiated primary human tissue, 
it may expand the paradigm that the biological effectiveness of high LET radiations in regards to 
cell kill and mutagenesis is due solely to induction of localised complex DNA DSBs. For the 
therapeutic use of alpha particles and heavy ions, the presence (or absence) of pan-nuclear 
gamma-H2AX in high LET irradiated tissues will help confirm that the calculated doses to 
tissues at risk match those actually delivered.  
 
Materials and methods 
Blood collection and lymphocyte isolation 
After obtaining ethical approval from Queen’s University Belfast Medical School Ethics Board 
(Ref 12.13v2) and informed consent from donors, peripheral blood from healthy donors (no 
known previous medical radiation exposures, aged 24-31) was collected into EDTA vacutainer 
tubes. Lymphocytes were isolated from the blood using Histopaque-1077 solution (Sigma-
Aldrich) and resuspended in RPMI-1640 (supplemented with 10% foetal calf serum, 1% L-
glutamine and 1% penicillin/streptomycin) at 37°C.  
Alpha particle and X-irradiation of Lymphocytes 
For alpha particle irradiation, lymphocytes were irradiated under sterile conditions with a 1 µCi 
americium-241 source, which decays to give ~5.45 MeV alpha particles. Lymphocytes were 
irradiated in 20 µl of media at a concentration of 2x107 cells per ml on top of the source 
separated by a 0.9 µm Mylar foil. Lymphocytes were irradiated for eight minutes, being 
aspirated every two minutes, giving a non homogenous exposure to the cell population with the 
majority of the cells containing zero foci, representing the partial body non-homogenous 
exposures to radium-223 seen clinically. For X-ray exposures lymphocytes were uniformly 
irradiated with 1 Gy at 225 kVp in flasks. Lymphocytes were also irradiated with X-rays on 
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Mylar and no difference in gamma-H2AX signal (breaks or nuclear intensity) was observed 
between lymphocytes irradiated in flasks and on Mylar. All controls were sham irradiated and all 
irradiations took place at 40C. 
Alpha particle and X-irradiation of Fibroblasts 
For alpha particle irradiation, cultured normal human Fibroblasts (AGO1522) were grown and 
irradiated on 0.9 µm Mylar foil using the1 µCi americium-241 source discussed above. 
AGO1522 cells were irradiated with 2 Gy of alpha particles to 50 % of the cell population (the 
limit of our alpha irradiation setup) producing a heterogeneous sample of irradiated and 
unirradiated cells, again mimicking the partial body non-homogenous exposures to radium-223 
seen clinically. For X-ray exposures AGO1522 cells were uniformly irradiated with 4 Gy at 225 
kVp in flasks. AGO1552 cells were also irradiated with X-rays on Mylar and no difference in 
gamma-H2AX signal (breaks or nuclear intensity) was observed between cells irradiated in 
flasks and on Mylar. All controls were sham irradiated and all irradiations took place at 40C. 
Inhibitor treatment 
ATM inhibitor KU60019 and DNAPK inhibitor NU7441 (Tocris bioscience, UK) were used at a 
concentration of 10 µM. All inhibitors were dissolved in DMSO and controls were treated with 
DMSO only. Cells treated with inhibitors or DMSO only were treated for one hour before 
irradiation. 
Fixation and staining of cells 
Lymphocytes were dried onto Superfrost plus slides (VWR), fixed using 4 % formaldehyde/PBS 
(or 100% methanol for gamma-H2AX/p-DNAPK) for 10 minutes, washed in PBS, permeabilised 
using 0.5 % (v/v) Triton-X/PBS (skipped for methanol fixed cells) for 10 minutes then washed in 
PBS. Blocking was achieved using 1 % (w/v) bovine serum albumin (BSA) in PBS for 30 
minutes. Cells were then incubated with a dual combination of either 1:2000 mouse gamma-
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H2AX antibody (Millipore 05-636), 1:2000 rabbit 53BP1 antibody (Bethyl Laboratories NB100-
304), 1:2000 mouse phospho-serine 1981 ATM antibody (Millipore MAB3806) and 1:1000 
rabbit phospho-serine 2056 DNAPK antibody (Abcam ab18192) in 1% BSA/PBS for 1 hour at 
room temperature. Cells were then washed in 1% BSA/PBS, incubated in 1:2000 anti-mouse 
AlexaFluor 488 conjugated antibody (Invitrogen A11029) and 1:2000 anti-rabbit AlexaFluor 568 
conjugated antibody (Invitrogen A11036) in 1 % BSA/PBS for 1 hour at room temperature. Cells 
were then washed in PBS, dried, mounted with a cover slip using Prolong gold antifade with 
DAPI (Invitrogen P36931) and left to dry for 24 hours at room temperature in the dark. Slides 
were analysed with a Zeiss epifluorescence microscope using a x63 objective. For the apoptosis 
assay the FLICA Poly Caspase kit (Immunochemistry technologies) was used as per the 
manufacturer’s instructions.  
Immunoblotting 
AGO1552s were trypsinised off Mylar, lysed and protein concentration determined using the 
Bradford assay. Lysates were then run on 12% acrylamide gels (8% for p-ATM), transferred to a 
nitrocellulose membrane, blocked in 5% milk followed by incubation overnight at 40C with anti-
gamma-H2AX (see above), anti-p-ATM (see above), anti-Actin, anti-BCL-2, anti-Bax, anti-
Caspase 3, anti-Caspase 7, anti-Caspase 9 and anti-p-p53 (Cell Signalling) primary antibodies. 
Membranes were then washed in TBS-0.1% tween20 and incubated at room temperature for 1 h 
with HRP-conjugated secondary antibodies (Cell Signalling). Luminata (Merck Millipore) was 
used for chemiluminescence and membranes were visualised on a Syngene G:BOX with 
exposure time set automatically to prevent saturation. AGO1552 cells were used for western 
blotting to as the number of alpha particles delivered to each adhering fibroblast cell could be 
kept far more consistent than with lymphocytes in suspension. 
Software and statistics 
Microscope images were taken using an Axiovision microscope (Zeiss) with cells identified and 
intensity measurements made using Volocity software (Perkinelmer). For non-foci intensity 
measurements, gamma-H2AX foci were removed from each cell in each image and the 
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remaining gamma-H2AX intensity quantified. The fold intensity change between time matched 
irradiated and sham-irradiated controls was then calculated. ImageJ (NIH) was used to generate 
cell images and measure foci size and intensity. Graphs were made using PRISM 5 (Graphpad 
Software) and all statistics were performed using SPSS (IBM). Foci counts were made manually 
by eye at x63 magnification. All error bars represent the standard error of the mean of three 
experiments. At least 50 cells were scored for foci counting and intensity measurements for all 
data points, with 200 scored for alpha particle irradiated samples to account for the low number 
of cells with tracks. For the track vs intensity analysis, 79 cells were used. 
 
Results 
Alpha particles, but not X-rays, induce pan-nuclear phosphorylation of H2AX and ATM in 
primary human lymphocytes and normal human fibroblasts 
Observations that alpha particle irradiated lymphocytes displayed intense gamma-H2AX (Fig 
1A) and phospho-ATM (Fig 1B) signal vs X-ray irradiated lymphocytes and controls led to a 
more in depth analysis. After exposure to alpha particles or X-rays, an increase in nuclear foci is 
observed, indicated by co-localising gamma-H2AX/53BP1, phospho-ATM/53BP1 and gamma-
H2AX/p-DNAPK focus formation (Figures 2A, 2B and 2C). However alpha particles, but not X-
rays, induced pan-nuclear phosphorylation of both H2AX and ATM in lymphocytes, which did 
not co-localise with 53BP1. This nuclear intensity was less than the individual focus intensity 
(average gamma-H2AX focus intensity was 84% greater than the nuclear intensity, p = 0.0077, 
Students t test). Gamma-H2AX intensity measurements of each irradiated nucleus (excluding 
intensity contribution from each focus) showed a greater than two fold increase in nuclear 
intensity at 1 and 4 hours post exposure to alpha particles (Figure 2D). A similar pattern was also 
observed with phospho-ATM, with intensity measurements significantly elevated against 
baseline at 1, 4 and 24 hours post exposure (Figure 2E). Alpha particle irradiation failed to 
induce any significant pan-nuclear phosphorylation of DNAPK (Figure 2F).  
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Both alpha particle induced gamma-H2AX foci and intensity reduced over time, however these 
two processes occurred at different rates (Figure 3A). While 24 hour foci numbers remain above 
50% of the peak numbers seen at 1 hour, 24 hour intensity values dropped to below 20% of the 1 
hour peak. The pan-nuclear phosphorylation of H2AX and ATM was confirmed not to be linked 
to apoptosis through the quantification of activated caspases which showed few apoptotic 
lymphocytes present <8 hours post exposure to alpha particles (Figure 3B). When comparing the 
size of alpha particle vs. X-ray induced gamma-H2AX foci, at both 1 and 24 hours alpha particle 
induced foci were more than 2 times (and significantly) larger than X-ray induced foci (Figure 
3C). There was no significant difference in the size of 1 h and 24 h foci for alpha particles or X-
rays. Gamma-H2AX intensity was also significantly higher at both 1 h and 24 h in alpha particle 
induced foci vs. X-rays (Figure 3C). However while there was no significant difference between 
X-ray foci intensity at 1 and 24 h, alpha particle induced foci were significantly more intense at 1 
h when compared to 24 h.  
As observed in lymphocytes, alpha particle irradiated normal human fibroblasts, AGO1552s, 
also displayed pan-nuclear phosphorylation of H2AX outside of DNA DSBs whereas X-
irradiated cells did not (Figure 4A). Confirming this by western blot, both Gamma-H2AX and 
phospho-ATM can be detected in irradiated cell lysates at 1 hour post exposure for both and only 
gamma-H2AX at 24 hours (Figure 4B), with no intense bands detected outside their expected 
regions on the membrane. Probing for proteins involved in apoptosis, p-p53 is strongly up 
regulated in the X-irradiated AGOs and less so in the alpha-irradiated AGOs (Fig 4B). Perhaps 
unexpectedly, both the pro-apoptotic BAX and anti-apoptotic BCL-2 proteins were strongly up 
regulated in all irradiated samples post exposure (Figure 4B). Both cleaved caspase 7 and 9 were 
detected in all irradiated and unirradiated AGO samples (Figures 4D and 4E) while cleaved 
caspase 3, the terminal effector caspase is absent in both X- and alpha-irradiated AGO lysates at 
both 1 and 24 hours post exposure (Figure 4C). A DU-145 prostate cancer cell line treated with 
SAHA (a histone deacetylase inhibitor) was used as a positive control (Figures 4C-E).  
 
Alpha particle track number, not DSBs induced by each track, determine pan nuclear 
gamma-H2AX intensity 
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While it was noted that cells containing greater foci numbers also had higher gamma-H2AX 
intensity values in alpha particle irradiated cells, we decided to determine whether this was a 
result of  the number of DSBs induced or the number of alpha particles which had traversed the 
nucleus (a single alpha particle induced anywhere between 1-6 observable foci per track). Cells 
were classified as having one, two or three tracks per cell (Figure 5A) and intensity 
measurements taken. Plotting gamma-H2AX intensity vs. foci per cell for one (Figure 5B), two 
(Figure 5C) or three tracks (Figure 5D) apart from each other, no significant correlations were 
observed. However once all the data points for one, two and three tracks was analysed together, a 
strong, significant correlation between intensity and foci was observed (Figure 5E). This 
suggests that the intensity of pan-nuclear phosphorylation of H2AX is dependent on the number 
of alpha particles which have traversed the nucleus and caused at least one DSB. The actual 
number of DSBs each track induces above one appeared to not influence the intensity of pan-
nuclear gamma-H2AX.  
 
ATM and not DNAPK drives the pan nuclear phosphorylation of H2AX after exposure to 
alpha particles 
Through the use of potent inhibitors of ATM and DNAPK, the kinase responsible for the 
activation of H2AX after exposure to alpha particles and X-rays was investigated. The use of the 
ATM inhibitor, KU60019 significantly reduced the pan-nuclear intensity of gamma-H2AX and 
p-ATM after exposure to alpha particles (Figure 6A). Recruitment of 53BP1 to DSBs was 
seemingly unaffected while gamma-H2AX foci intensity was also reduced. Treatment with 
KU60019 also abolished the phosphorylation of DNAPK at serine 2056. The DNAPK inhibitor, 
NU7441 failed to have significant impact of the pan-nuclear phosphorylation of either H2AX or 
ATM (Figure 6B). Fold gamma-H2AX (Figure 6C) and phospho-ATM (Figure 6D) intensities 
over time are further reduced by a combination of KU60019 and NU7441. NU7441 did not 
prevent the phosphorylation of DNAPK at serine 2056 or DNAPKs recruitment to DSBs, 
however the number of DSBs at 24 hours post X-irradiation was increased in NU7441 treated 
lymphocytes vs. DMSO treated controls (Figure 7) demonstrating that the inhibitor is reducing 
the rate of DNA repair.  
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Discussion 
Here we have confirmed that high LET alpha particles (~135 keV/μm) induce pan-nuclear 
phosphorylation of H2AX and ATM previously demonstrated by Meyer et al [9], who used 
heavy ions ranging from 290-15000 keV/μm to irradiate cells. While not fixed, it has been 
suggested that the lower limits for high LET radiation is 50 keV/μm [14-15] and this 
phenomenon appears to be confined to radiations of high LET as neither X-rays nor 20 MeV 
protons [16] (2.6 keV/μm) induced pan-nuclear gamma-H2AX.  
Importantly, high LET induced pan-nuclear gamma-H2AX is a cell cycle independent process, 
as the signal was observed in both cycling AGO1522 primary human fibroblasts and in quiescent 
primary human lymphocytes. Our work using fresh (taken and irradiated on the day) primary 
human lymphocytes further suggests that this is unlikely to be an artefact produced by cell 
culture.  
Immunofluorescence failed to detect activated caspases in alpha particle irradiated lymphocytes 
while immunoblotting detected low levels of cleaved caspase 7 and 9 in all our AGO1522 
samples (even unirradiated controls) whereas cleaved caspase 3 was only observed in SAHA 
treated DU-145 cells. In AGO1522s (a cell line well known to be apoptosis resistant), the up 
regulation of both pro and anti apoptotic factors likely represents separate pathways pushing 
towards a survive or die response, although up regulation of BCL-2 has been shown to block pro 
BAX apoptosis [17, 18] suggesting that the strong BCL-2 induction we observe suggests the 
cells are neither apoptotic or necrotic. Perhaps the single biggest indicator that at 1 hour post 
alpha particle irradiation cells are not dying (when gamma-H2AX and phospho-ATM signal is 
greatest) is that the DNA content, structure and morphology of the cells remains normal. For 
both lymphocytes and AGO1552s the cells do not appear in any way different from controls or 
X-ray irradiated cells, when it is known that hallmarks of both apoptosis and necrosis is aberrant 
cell morphology and DNA fragmentation [19-21]. 
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The pan-nuclear activation of H2AX here was driven primarily through ATM, with DNAPK 
playing little if any role. This was in contrast to Meyer et al [9] who observed that ATM and 
DNAPK shared the role of triggering pan-nuclear gamma-H2AX after high LET irradiation. It is 
known that there is redundancy between the kinases involved in DNA repair with H2AX being a 
target of ATM [22], ATR [23] and DNAPK [24]. Our data suggests that at DSBs, H2AX is 
phosphorylated by DNAPK as in the presence of KU60019, gamma-H2AX foci were still 
present (albeit much reduced). Whereas pan-nuclear phosphorylation of H2AX appeared to be 
regulated via ATM, as cells treated with KU60019 displayed reduced pan-nuclear 
phosphorylation after alpha particle irradiation. This would make sense as pan-nuclear phospho-
ATM is observed after high LET radiation which would be required for activation of H2AX 
genome wide. Phospho-DNAPK on the other hand was only present at DSBs, reinforcing the 
notion that it only phosphorylates H2AX at DSBs as it is not seen dispersed throughout the 
nucleus. It should be noted however that previous work has shown that ATM inhibition did not 
alter DNAPK phosphorylation at S2056 due to it being an autophosphorylation site [25]. An 
explanation for this difference could be that lymphocytes being non dividing cells are more 
reliant on ATM for DSB detection and recruitment of repair factors to the break, with inhibition 
of ATM strongly suppressing DNAPK autophosphorylation. 
The role of ATM and DNAPK in the repair of DSBs has been well documented, with DNAPK 
identified as having a major role in the repair of the majority of DSBs [26, 27]. ATMs role 
appears to be more subtle, with suggestions that this kinase is involved in the repair of DSBs that 
require re-sectioning and those breaks lying within heterochromatic regions [28, 29], along with 
its critical role in DNA damage signalling [30] and apoptosis [31]. With ATM/DNAPK 
inhibition reducing the rate of DSB repair, but not altering pan-nuclear intensity at 24 hours post 
exposure, suggests that pan-nuclear gamma-H2AX damage (if damage at all) is not repaired by 
either non homologous end joining (NHEJ) or homologous recombination (HR) (lymphocytes 
being quiescent do not have access to HR). 53BP1 and phospho-DNAPK are known markers of 
DSBs and the lack of a pan-nuclear signal for either of these proteins suggest this does not 
represent DSBs. The evidence suggests pan-nuclear gamma-H2AX induced by high LET 
particles is not the result of either direct or indirect ionisations as the penetrating distance of delta 
electrons is in the nm range [32], with pan-nuclear signal observed throughout the nucleus up to 
several μm away from any DSBs.  
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While it first appeared that gamma-H2AX pan nuclear intensity was determined by the number 
of DSBs induced, this turned out to be a casual correlation. The number of alpha particle tracks 
which had traversed each lymphocyte determined the relative strength of the pan-nuclear 
gamma-H2AX signal regardless of the number of DSBs the track induced. The consequence of 
this could be fragmentation of the DNA over Mbps around each DSB, which when overlapping 
in the case of alpha particle tracks saturates the signal. Separate tracks inducing as many or fewer 
foci may produce a greater signal due to less overlap of fragmenting DNA [33-35] 
The presence of pan-nuclear gamma-H2AX/p-ATM signal after high LET irradiation is relevant 
to both the fields of radioprotection and clinical oncology. Previously there have been no distinct 
molecular markers of exposure to high LET radiation, making biological dosimetry in radiation 
protection dependent on the presence of complex chromosomal rearrangements found within 
high LET irradiated cells, a difficult and time consuming assay [36]. The use of gamma-H2AX 
foci scoring for X-irradiated cells has already been proposed [3, 37] and the presence of pan-
nuclear gamma-H2AX and delayed foci repair in high LET irradiated lymphocytes may aid in 
the differentiation between radiation exposures of differing LET. For clinical oncology, the 
recent approval of the alpha particle emitting radionuclide, Xofigo (previously Alpharadin, 
radium223) for the treatment of bone metastases [10] has revealed the need of further research in 
determining patient uptake and response to treatment to new radical radionuclide therapies. 
Individual patient response to high LET damage is especially of interest as it has previously been 
shown that in women who received radiotherapy for breast cancer that those who had slower 
rates of DSB repair in their lymphocytes also displayed greater normal tissue toxicity [38]. 
Greater understanding of the molecular damage and response to high LET radiations is required 
to further comprehend their biological effects.  
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Figure Legends 
Figure 1. Grey scale image of Gamma-H2AX (A) and phospho-ATM (B) in primary human 
lymphocytes. The alpha particle irradiated samples contain a heterogeneous population of 
irradiated and unirradiated cells.  
Figure 2. Alpha particles, but not X-rays, induce pan nuclear phosphorylation of H2AX and 
ATM in lymphocytes. Primary human lymphocytes were irradiated with alpha particles 
displayed gamma-H2AX (A) and phospho-ATM (B) signal which did not correlate with 53BP1. 
No phospho-DNAPK signal was observed outside of alpha particle induced DSBs (C). Non-foci 
intensity measurements showing fold change against controls for gamma-H2AX (D), phospho-
ATM (E) and phospho-DNAPK (F). p = < 0.05*, <0.01** and < 0.001***, students t test.  
Figure 3. (A) Gamma-H2AX loss over 24 hours following alpha particle irradiation for foci 
(right axis) and intensity (left axis). The number of apoptotic lymphocytes detected (represented 
by being FLICA positive) steadily increased between 1-24 hours post alpha particle irradiation 
(B). Gamma-H2AX foci size and intensity was significantly greater compared to X-rays at both 
1 and 24 hours post exposure. p = < 0.05* and<0.01**, students t test.  
Figure 4. Immuno-grey scale image of unirradiated or 1 Gy X- or alpha irradiated AGO1552 
fibroblasts (A). (B) Western blots of radiation responsive proteins involved in DNA repair, cell 
cycle check points and apoptosis to 4 Gy X-rays or 2 Gy alpha particles. Western blots of 
caspases/cleaved caspases 3 (C), 7 (D) and 9 (E). DU-145 cells were treated with 1 µM SAHA. 
The region of cleaved caspases is indicated by the arrows. 
Figure 5. Immunofluorescent image of lymphocytes containing one, two or three alpha particle 
tracks (A). Gamma-H2AX intensity plotted against gamma-H2AX foci per cell in lymphocytes 
containing one (B), two (C) or three (D) alpha particle tracks or all three data sets combined (E). 
Pearson product-moment correlation coefficient was used to determine significant correlation 
between intensity and foci, which was only observed in the combined data set. 
Figure 6. The ATM inhibitor, KU60019, significantly reduces gamma-H2AX, phospho-ATM 
and phospho-DNAPK intensity in alpha particle irradiated lymphocytes (A). (B) The DNAPK 
inhibitor, NU7441, failed to have an effect on either gamma-H2AX, phospho-ATM or phospho-
DNAPK foci or pan nuclear intensity (B). Intensity decreases after inhibitor treatment in alpha 
particle irradiated lymphocytes for gamma-H2AX (C) and phospho-ATM (D) p = < 0.05*, 
<0.01** and < 0.001***, students t test.  
Figure 7. Gamma-H2AX/53BP1 foci counts in lymphocytes irradiated with 1 Gy X-rays. Cells 
were treated with either KU60019 (ATMi), NU7441 (DNAPKi), a combination of both or 
DMSO only (IR). 
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